Optimizing TMS Pulse Protocols for Reward Processing in Smokers
Official title: Determining the Optimal Pulse Protocol for TMS Induced Change in Reward Positivity
Run by Rutgers, The State University of New Jersey · NCT06695884 · Data updated 2026-11-12
This study is trying out different brain stimulation techniques to see if they can help smokers manage their cravings and make better decisions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Newark, New Jersey) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | November 18, 2025 |
| Trial ID | NCT06695884 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are nicotine-dependent individuals aged 18 to 55 who are in stable mental and physical health.
✕Probably not a fit
Patients with contraindications to MRI or rTMS, or those with a history of neurological disorders, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to identify the most effective transcranial magnetic stimulation (TMS) pulse protocols to modulate reward activity in nicotine-dependent individuals. It will involve a randomized controlled design with two sessions, where participants will receive either excitatory or inhibitory TMS protocols while engaging in decision-making tasks. The study will also assess the impact of these protocols on craving levels and decision-making capacity. Participants will be required to abstain from smoking for four hours prior to each session to ensure accurate measurement of outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for nicotine use disorder by enhancing reward processing and decision-making in smokers.
How similar studies have gone: Other studies have shown promise in using TMS for modulating reward processing, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Nicotine dependent individuals (according to the Alcohol, Smoking and Substance Involvement Screening Test nicotine dependence score). 2. Be between the ages of 18 and 55 years old. 3. Not received substance abuse treatment within the previous 30 days. 4. Be in stable mental and physical health. 5. If female, test non-pregnant. 6. No evidence of focal or diffuse brain lesion on MRI. 7. Be willing to provide informed consent. 8. Be able to comply with protocol requirements and likely to complete all study procedures. Exclusion Criteria: 1. Contraindication to MRI (e.g., presence of metal in the skull, orbits or intracranial cavity, claustrophobia). 2. Contraindication to rTMS (history of neurological disorder or seizure, increased intracranial pressure, brain surgery, or head trauma with loss of consciousness for \> 15 minutes, implanted electronic device, metal in the head, or pregnancy). 3. History of autoimmune, endocrine, viral, or vascular disorder affecting the brain. 4. History or MRI evidence of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment. 5. Life time history of mental disorders such as: Bipolar Affective disorder (BPAD), Schizophrenia, Post-traumatic Stress disorder (PTSD) or Dementia or Major Depression. 6. uninterruptable central nervous system medication
Where it's running
-
Rutgers University - Newark
Newark, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Travis E Baker, PhD — Rutgers University
- Study coordinator: Travis E Baker, PhD
- Email: travis.e.baker@rutgers.edu
- Phone: 973-353-5485
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Temporal interference stimulation for nicotine vaping addiction
This trial will test whether a non-invasive brain stimulation method called temporal interference can lower cravings and reduce vaping in adults who use nicotine.
-
Tobacco cessation program for community behavioral health sites in Chicago
This project will test a community-informed smoking cessation program to help adults who smoke and receive services at behavioral health organizations in Chicago.
-
tDCS plus varenicline to help people quit smoking
This will test if adding noninvasive tDCS brain stimulation to varenicline helps adults who smoke at least 8 cigarettes a day quit and stay smoke-free.
-
Real-time telecounselling for quitting nicotine addiction
This study is testing whether real-time telecounseling can help people quit smoking by providing them with weekly therapy sessions.
-
How cooling ingredients and menthol change the feel of nicotine e-liquids for adult vapers
This project will test whether cooling chemicals (WS-3, WS-23) and menthol make nicotine e-liquids more appealing or habit-forming for adults who use e-cigarettes.
-
Identifying the best brain target for TMS to help smokers
This study is testing if a specific brain stimulation technique can help smokers by improving their decision-making and reducing cravings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.